000 01306 a2200337 4500
005 20250513110604.0
264 0 _c19970123
008 199701s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/s0006-2952(96)00521-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPhillips, R M
245 0 0 _aBioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase.
_h[electronic resource]
260 _bBiochemical pharmacology
_cDec 1996
300 _a1711-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xmetabolism
650 0 4 _aAziridines
_xmetabolism
650 0 4 _aBiotransformation
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDNA
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIndolequinones
650 0 4 _aIndoles
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aNAD(P)H Dehydrogenase (Quinone)
_xmetabolism
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTumor Cells, Cultured
773 0 _tBiochemical pharmacology
_gvol. 52
_gno. 11
_gp. 1711-8
856 4 0 _uhttps://doi.org/10.1016/s0006-2952(96)00521-7
_zAvailable from publisher's website
999 _c8977589
_d8977589